Related Experiment Videos
Methyltrienolone, a specific ligand for cellular androgen receptors
Steroids
|August 1, 1975
Summary
Methyltrienolone (R 1881) is a potent androgen that binds strongly to rat prostate cytosol. It is a valuable tool for studying androgen receptors, especially in human tumors, as it avoids interference from plasma binding proteins.
Area of Science:
- Endocrinology
- Molecular Biology
- Androgen Receptor Research
Background:
- Androgens play crucial roles in various physiological processes.
- Studying androgen receptors is vital for understanding hormone-dependent diseases like prostate cancer.
- Existing methods for androgen receptor detection can be confounded by plasma protein binding.
Purpose of the Study:
- To evaluate Methyltrienolone (R 1881) as a specific ligand for androgen receptor detection.
- To investigate the binding characteristics of Methyltrienolone (R 1881) in comparison to other androgens.
- To demonstrate the utility of Methyltrienolone (R 1881) in circumventing plasma protein interference.
Main Methods:
- Radioligand binding assays using rat prostate cytosol.
- Comparison of binding affinities with androstanolone.
- Assessment of binding to human sex steroid plasma binding protein (SBP).
Main Results:
- Methyltrienolone (R 1881) exhibits high affinity binding to rat prostate cytosol, exceeding that of androstanolone.
- Methyltrienolone (R 1881) does not bind to human sex steroid plasma binding protein (SBP).
- This differential binding profile makes Methyltrienolone (R 1881) suitable for specific androgen receptor studies.
Conclusions:
- Methyltrienolone (R 1881) is a potent and specific androgen analog.
- Its lack of binding to SBP makes it an ideal tool for studying androgen receptors in biological samples, particularly in the presence of plasma contamination.
- This ligand facilitates the accurate detection and investigation of androgen receptors in contexts like human tumors.